CANNAPHARMARX, INC. Deferred State and Local Income Tax Expense (Benefit)
CANNAPHARMARX, INC. (CPMD) reported Deferred State and Local Income Tax Expense (Benefit) of $206.91 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-31
- CANNAPHARMARX, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was $206.91K, a 377.85% increase from fiscal 2024.
- CANNAPHARMARX, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was $43.30K.
- CANNAPHARMARX, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was -$56.05K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $206.91K 10-K · filed 2026-03-31 |
| 2024-12-31 | $43.30K 10-K · filed 2026-03-31 |
| 2023-12-31 | -$56.05K 10-K · filed 2025-04-10 |